EX-FILING FEES 7 ex107.htm

 

Exhibit 107

 

Calculation of Filing Fee Tables

 

Form S-3

(Form Type)

 

Imunon, Inc.

(Exact Name of Registrant as Specified in its Charter)

 

Table 1: Newly Registered and Carry-Forward Securities

 

  

Security

Type

 

Security

Class

Title

 

Fee

Calculation

Rule

  

Amount

Registered

  

Proposed

Maximum

Offering

Price

Per Unit

  

Maximum

Aggregate

Offering

Price (1)(2)

  

Fee

Rate

  

Amount of

Registration

Fee

  

Carry

Forward

Form

Type

  

Carry

Forward

File

Number

  

Carry

Forward

Initial

Effective

Date

  

Filing Fee

Previously

Paid In

Connection

with

Unsold

Securities

to be

Carried

Forward

 
Newly Registered Securities 
Fees to be Paid  Equity  Common stock, par value $0.01 per share   457(o)    (3)   (3)   (3)                              
   Equity  Preferred stock, par value $0.01 per share   457(o)    (3)   (3)   (3)                              
   Debt  Debt Securities (4)   457(o)    (3)   (3)   (3)                              
   Equity  Warrants   457(o)    (3)   (3)   (3)                              
   Other  Rights   457(o)    (3)   (3)   (3)                              
   Other  Units   457(o)    (3)   (3)   (3)                              
   Unallocated (Universal) Shelf      457(o)    (3)   (3)   $75,000,000.00 (5)   0.00014760   $11,070.00                     
Carry Forward Securities 
Carry Forward Securities                                                        
                                                         
   Total Offering Amount        $75,000,000    0.00014760   $11,070.00                     
   Total Fees Previously Paid                   N/A                     
   Total Fee Offsets                   $10,123.76 (6)                    
   Net Fee Due                  $946.24                     

 

  (1) Pursuant to Rule 416(a) promulgated under the Securities Act of 1933, as amended (the “Securities Act”), this Registration Statement shall also cover any additional shares of common stock of Imunon, Inc. (the “Registrant”) that become issuable with respect of the securities identified in the above table by reason of any stock dividend, stock split, recapitalization or other transaction effected without the Registrant’s receipt of consideration that results in an increase in the number of outstanding shares of Registrant’s common stock.
     
  (2) Estimated solely for the purpose of calculating the amount of the registration fee in pursuant to Rule 457(o) under the Securities Act.

 

 
 

 

 

  (3) An indeterminate number or aggregate principal amount, as applicable, of securities of each identified class is being registered as may from time to time be offered on a primary basis at indeterminate prices, including an indeterminate number or amount of securities that may be issued upon the exercise, settlement, exchange or conversion of securities offered hereunder, which together shall have an aggregate initial offering price not to exceed $75,000,000. Separate consideration may or may not be received for securities that are issuable upon conversion of, or in exchange for, or upon exercise of, convertible or exchangeable securities.
     
  (4) If any debt securities are issued at an original issue discount, the offering price of such debt securities shall be in such greater principal amount at maturity as shall result in an aggregate offering price not to exceed $75,000,000, less the aggregate dollar amount of all securities previously issued hereunder.
     
  (5) Estimated solely for purposes of calculating the registration fee. Subject to Rule 462(b) under the Securities Act, the aggregate initial offering price of all securities issued by the Registrant pursuant to the unallocated universal shelf base prospectus (inclusive of any shares of common stock of the Registrant issued pursuant to the sales agreement prospectus) will not exceed $75,000,000.
     
  (6) Represents the total of the fee offsets claimed pursuant to Rule 457(p) under the Securities Act for the portion of registration fee previously paid with respect to unsold securities, as set forth in Table 2. The Registrant has terminated the offerings related to the unsold securities associated with the claimed offset.

 

Table 2: Fee Offset Claims and Sources

 

   Registrant or
Filer Name		  Form or
Filing
Type		  File
Number		  Initial
Filing
Date		  Filing
Date		  Fee
Offset
Claimed		   Security
Type
Associated
with Fee
Offset
Claimed		  Security
Title
Associated
with Fee
Offset
Claimed		  Unsold
Securities
Associated
with Fee
Offset
Claimed		  Unsold
Aggregate
Offering
Amount
Associated
with Fee
Offset
Claimed		   Fee Paid
with Fee
Offset
Source		 
Rule 457(p) 
Fee Offset Claims  Imunon, Inc.  S-1  333-276174  December 20, 2023     $ 3,542.40 (1)  Equity  Common stock, par value $0.01 per share  Common stock, par value $0.01 per share  $8,000,000.00   $1,180.80 
   Imunon, Inc.  S-1  333-276174  December 20, 2023          Equity  Common Stock issuable upon exercise of Series A and Series B warrants  Common Stock issuable upon exercise of Series A and Series B warrants  $16,000,000.00   $2,361.60 
   Imunon, Inc.  S-3  333-254515  March 19, 2021     $6,581.36 (2)  Unallocated (Universal) Shelf  Unallocated (Universal) Shelf  Unallocated (Universal) Shelf  $60,324,149.70      
Fees Offset Sources  Imunon, Inc.  RW  333-276174     February 9, 2024                     $3,542.40 
   Imunon, Inc.  S-3  333-254515     March 19, 2021                     $10,910.00 
Total Fee Offset Claims                 $10,123.76                    

 

  (1) This offset claim relates to a registration statement on Form S-1 filed by the registrant on December 20, 2023 (File No. 333-276174), as amended on January 18, 2024 and February 9, 2024, registering up to $24,000,000 in aggregate principal amount of shares of common stock and warrants for sale by the Registrant (the “Prior S-1 Registration Statement”). The Prior S-1 Registration Statement was withdrawn by the Registrant on April 10, 2024. The Prior S-1 Registration Statement was not declared effective by the Securities and Exchange Commission, and no securities were issued or sold thereunder. As a result, the registrant has $24,000,000 of unsold securities and $3,542.40 in unused filing fees associated with the Prior S-1 Registration Statement. In accordance with Rule 457(p) under the Securities Act, the Registrant is using the unused filing fees to offset the filing fee payable in connection with this filing.
     
  (2) On March 19, 2021, the Registrant initially filed a Registration Statement on Form S-3 (File No. 333- 254515) (the “Prior S-3 Registration Statement”), which registered an aggregate amount of $100,000,000 of common stock, preferred stock, debt securities, warrants, rights and units to be offered by the Registrant from time to time. $39,675,850.30 of securities were sold pursuant to the Prior S-3 Registration Statement, and the Prior S-3 Registration Statement expired on March 30, 2024, and all offerings thereunder have been completed or terminated. As a result, the registrant has $60,324,149.70 of unsold securities and $6,581.36 in unused filing fees associated with the Prior S-3 Registration Statement. In accordance with Rule 457(p) under the Securities Act, the Registrant is using the unused filing fees to offset the filing fee payable in connection with this filing.